Alector Inc (ALEC)
5.22
+0.03
(+0.58%)
USD |
NASDAQ |
May 09, 16:00
5.22
0.00 (0.00%)
After-Hours: 20:00
Alector Profit Margin (Quarterly): -227.0% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -227.0% |
| December 31, 2023 | -272.8% |
| September 30, 2023 | -488.3% |
| June 30, 2023 | 2.45% |
| March 31, 2023 | -277.1% |
| December 31, 2022 | -363.1% |
| September 30, 2022 | -310.7% |
| June 30, 2022 | 12.38% |
| March 31, 2022 | -182.3% |
| December 31, 2021 | -397.4% |
| September 30, 2021 | 69.40% |
| June 30, 2021 | -839.6% |
| March 31, 2021 | -1.27K% |
| Date | Value |
|---|---|
| December 31, 2020 | -1.08K% |
| September 30, 2020 | -892.7% |
| June 30, 2020 | -1.43K% |
| March 31, 2020 | -558.1% |
| December 31, 2019 | -508.7% |
| September 30, 2019 | -1.18K% |
| June 30, 2019 | -355.1% |
| March 31, 2019 | -331.1% |
| December 31, 2018 | -190.0% |
| September 30, 2018 | -235.5% |
| June 30, 2018 | -156.4% |
| March 31, 2018 | -171.5% |
| December 31, 2017 | -319.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.43K%
Minimum
Jun 2020
69.40%
Maximum
Sep 2021
-527.0%
Average
-380.2%
Median
Profit Margin (Quarterly) Benchmarks
| AbbVie Inc | 11.12% |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -70.54% |
| Return on Assets | -17.81% |
| Return on Invested Capital | -70.54% |
| Operating Margin (Quarterly) | -275.0% |
| Return on Net Operating Assets | -225.9% |